
Dizialarm 32mg Tablet SR
Marketer
Ryon Pharma
Salt Composition
Betahistine (32mg)
Overview Dizialarm 32mg Tablet SR
Meniere's disease, an inner ear disorder causing vertigo, tinnitus, and hearing loss (potentially due to excess inner ear fluid), is treated and prevented with the sustained-release Dizialarm 32mg tablet. This medication alleviates symptoms by reducing fluid buildup. For optimal results, swallow the entire tablet with water at consistent times daily. Dosage and frequency are determined by your physician, and treatment may continue for months, even if symptoms improve, as directed. Common side effects include headache, nausea, and dyspepsia, along with possible abdominal pain and distension. Consuming the medication with food may lessen gastrointestinal discomfort. Consult your doctor before use if you have a peptic ulcer, asthma, or hypertension/hypotension, and disclose all other medications to ensure safe usage. Pregnant or breastfeeding individuals, or those attempting conception, should also seek medical advice prior to starting treatment.
Uses of Dizialarm 32mg Tablet SR
Managing Meniere's disease
Major Benefits of Dizialarm 32mg Tablet SR:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dizialarm 32mg Extended-Release Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Dizialarm 32mg Tablet SR:
- Headache
- Indigestion
- Nausea
- Stomach pain
- Bloating
How to use Dizialarm 32mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the 32mg Dizialarm SR tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, although consistent timing is recommended.
How Dizialarm 32mg Tablet SR works:
Dizialarm 32mg SR tablets contain a histamine-like compound that enhances inner ear circulation. This reduces the buildup of fluid, thereby lessening the pressure that triggers nausea, vertigo, and the rotational sensations characteristic of Ménière's disease. The medication also attenuates nerve impulses originating in the inner ear, providing further relief from Ménière's symptoms.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Dizialarm 32mg Tablet SR and alcohol consumption.
PregnancyCONSULT YOUR DOCTOR
Prolonged-release Dizialarm 32mg tablets might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Dizialarm 32mg tablets are likely not safe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Dizialarm 32mg sustained-release tablets.
KidneySAFE IF PRESCRIBED
Extended-release Dizialarm 32mg tablets are likely safe for individuals with kidney impairment. Current evidence indicates dose modification may not be necessary, but physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Data on Dizialarm 32mg Tablet SR use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Dizialarm 32mg Tablet SR :
Omit any missed Dizialarm 32mg Tablet SR dose and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Dizialarm 32mg Tablet SR
| Label | Value |
|---|---|
| Chemical Category | Histamine-like compound |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Active Class | Meniere's Disease and Histamine Analogs |
